The aim of this study was to evaluate the Ang et al. IHC classification, the MUC5AC marker, molecular mutations, and clinicopathological factors in order to identify prognostic factors in a cohort of resected AA tumours collected in the AGEO cohort. This evidence concerns the gene MUC5AC and neoplasm.